Biogen Pharmachem Industries Balance Sheet Annual

BSE: 531752 | NSE: - | ISIN: INE703D01023 | Sector: Investment Services

1.23 0.00 (0.00%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.02	0.13	0.08	0.01
Cashand Short Term Investments	0.02	0.13	0.08	0.01
Accounts Receivable- Trade Net	0.00	0.00	0.00	2.54
Total Receivables Net	0.05	0.03	0.01	2.55
Total Inventory	0.00	0.00	0.00	-
Other Current Assets Total	0.00	0.00	1.84	-
Total Current Assets	0.07	0.15	1.93	2.56
Property/ Plant/ Equipment Total- Net	0.00	0.00	0.00	0.00
Long Term Investments	5.44	8.85	6.95	9.49
Note Receivable- Long Term	51.31	45.82	46.06	42.20
Other Long Term Assets Total	0.00	-	0.00	-
Total Assets	56.82	54.83	54.95	54.25
Accounts Payable	0.00	0.00	0.00	0.06
Other Currentliabilities Total	0.30	0.24	0.82	0.05
Total Current Liabilities	0.30	0.24	0.82	0.11
Long Term Debt	0.00	0.00	0.00	0.00
Total Long Term Debt	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00
Total Liabilities	0.30	0.24	0.82	0.11
Common Stock Total	65.26	65.26	65.26	65.26
Retained Earnings( Accumulated Deficit)	-8.74	-10.67	-11.13	-11.12
Total Equity	56.52	54.59	54.13	54.14
Total Liabilities Shareholders' Equity	56.82	54.83	54.95	54.25
Total Common Shares Outstanding	65.26	65.26	65.26	65.26
Tangible Book Valueper Share Common Eq	0.87	0.84	0.83	0.83
Notes Payable/ Short Term Debt	-	0.00	0.00	0.00
Deferred Income Tax	-	-	0.00	-